首页>
外国专利>
Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30
Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30
展开▼
机译:脂联素或acrp抑制湿性年龄相关性黄斑变性(AMD)30
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides new methods of treating wet type of age related macular degeneration by administering adiponectin (APN) or a functional fragment derived therefrom. One of the pathological complications of age related macular degeneration (AMD) is choroidal angiogenesis or choroidal neovascularization (CNV). The inventors discovered that the level of APN expression is significantly lower in the choroids of the laser-induced mouse model of choroidal angiogenesis or choroidal neovascularization (CNV) than that of the control mice and that administration of recombinant adiponectin (rAPN) or a peptide derived from the globular domain of the intact APN protein to the mouse model of CNV reduced the size of CNV significantly. These studies are the first to demonstrate the inhibitory effect of adiponectin on choroidal angiogenesis and thus provide the basis for treating a condition or disease involving angiogenesis, particularly age related macular degeneration, with administration of adiponectin.
展开▼